VU Research Portal
Towards personalized medicine in treatment and care of patients with peritoneal
metastases of colorectal cancer
de Cuba, E.M.V.
2016
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
de Cuba, E. M. V. (2016). Towards personalized medicine in treatment and care of patients with peritoneal
metastases of colorectal cancer.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ? Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Table of contents
Chapter 1 General introduction and outline of the thesis
Part I Clinical Decision Making / Treatment Allocation Chapter 2 Cytoreductive surgery and HIPEC for peritoneal metastases
combined with curative treatment of colorectal liver metastases - Systematic review of all literature and meta-analysis of observational studies -
Cancer Treat Rev. 2013 Jun;39(4):321-7
Chapter 3 Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC
Ann Surg Oncol. 2014 Mar;21(3):883-90 Part II Molecular Approach
– Possible Aids in Future Clinical Decision Making –
Chapter 4 Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer;
- Future possibilities for personalised treatment by use of biomarkers - Virchows Arch. 2012 Sep;461(3):231-43
Chapter 5 Adhesion molecules in peritoneal metastases of colorectal cancer: Function, prognostic relevance and therapeutic options -Accepted Clin Exp Metastasis April 2016
Chapter 6 Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy
Clin Exp Metastasis. 2016 Apr;33(4):297-307
Chapter 7 Angiogenesis related markers and prognosis after Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy for Metastatic Colorectal Cancer
Chapter 8 Glucose transporter 1 (SLC2A1) and vascular endothelial growth factor A (VEGFA) predict survival after resection of colorectal cancer liver metastasis
Ann Surg. 2016 Jan;263(1):138-45
Chapter 9 Tailoring heated intraperitoneal Mitomycin C for peritoneal metastases originating from colorectal carcinoma
- A translational approach to improve survival - Br J Cancer. 2015 Mar 3;112(5):851-6
